Does a β2-adrenergic receptor-WNK4-Na-Cl co-transporter signal cascade exist in the in vivo kidney?
Does a β2-adrenergic receptor-WNK4-Na-Cl co-transporter signal cascade exist in the in vivo kidney?
复制标题
体内肾脏中是否存在β2-肾上腺素受体-WNK4-Na-Cl协同转运蛋白信号级联?
DOI:
10.1038/nm.2809
复制
发表时间:
2012
期刊:
影响因子:
--
通讯作者:
Uchida S
中科院分区:
文献类型:
--
作者:
Aoki T.;他;Hara-Chikuma M;Hossain Khan MZ;Iimori S;Iimori S;Kanda E;Magdeldin S;Mandai S;Nishida H;Ohtaki H;Oi K;Sasaki S.;Susa K;Susa K;Uchida S
In their correspondence1, Uchida et al. respond to our paper2 in which we showed that renal β2-adrenergic receptor stimulation downregulates WNK4 expression and upregulates Na-Cl co-transporter (NCC) expression, hence contributing to the development of salt sensitive hypertension. We appreciate the study of Uchida et al. 1 and their findings, which confirm our original data that norepinephrine treatment contributes to the development of salt-sensitive hypertension, with a similar efficacy as in our study2. However, they did not detect any changes in WNK4 or NCC mRNA or protein levels in the kidney upon norepinephrine stimulation1.To address the concerns raised by Uchida et al. 1, we first reexamined whether WNK4 mRNA levels are decreased under norepinephrine stimulation. An obvious methodological difference between the two studies is that Uchida et al. 1 performed their salt diet experiments for 1 week in contrast to our 3-d regimen; we therefore performed all additional experiments after 1 week of salt diet. We collected RNA samples and analyzed them by both quantitative RT-PCR and northern blotting (Fig. 1a, b). In their study, Uchida et al. 1 chose a different primer set from the one used in our study2 (the ABI Mm00841400_m1